All questions are shown as received by the Trust.
I am writing to request information under the Freedom of Information Act 2000 regarding the screening protocols and procedures for Gestational Diabetes Mellitus (GDM) within your Trust, specifically pertaining to maternity services.
As part of a research project focusing on GDM screening and fetal outcomes, I am seeking detailed information on the following aspects:
1. Gestational Diabetes Mellitus Screening Methodology:
Please provide details on the current methods used by your Trust to screen for Gestational Diabetes Mellitus.
2. Timing of Screening:
At which gestational week do the majority of pregnant women undergo GDM screening within your Trust?
3. Early Screening for High-Risk Pregnancies:
Do you conduct GDM screening earlier for pregnant women deemed to be at very high risk? If so, please specify the criteria for determining high risk and the gestational week at which such screenings are conducted.
4. Administration of OGTT:
Who is responsible for administering the OGTT within your Trust? Additionally, where is the OGTT typically conducted (e.g., hospital clinic, community health center)?
5. Maternity-Related Risks Recorded in the Trust Risk Log:
Please disclose which maternity-related risks are logged in the Trust’s risk register or risk log.
6. Bank and agency Spending:
-Please provide bank spend for midwifery staff for the year 2023, by job grade.
-Please provide agency spend for midwifery staff for the year 2023, by job grade.